For example, breast cancer cells were found to be sensitive to growth inhibition by PI3K inhibitors without harbouring mutations in the PTEN or PIK3CA genes37; in addition, breast cancer cells with PTEN deficiency were found to be resistant to PI3K inhibitors38. This evidence concerns the gene PTEN and breast carcinoma.